Tom Brady opens up about his health amid GLP-1 surge: Water, movement and discipline
Seven-time Super Bowl champ Tom Brady says he wants to break the stigma around willpower as he joins eMed's mission to bring GLP-1 weight-loss support to workers.
The sober shift: Gen Z turning away from alcohol
Soft Bar founder and reality TV star Carl Radke breaks down America’s declining alcohol consumption, his sobriety journey and building a business around the booze-free movement on ‘Maria Bartiromo’s Wall Street.’
NFL legend Drew Brees highlights benefits from 'Stretch Zone' method
Former New Orleans Saint quarterback Drew Brees and Stretch Zone President and CEO Tony Zaccario discuss the growth of Stretch Zone franchises, the benefits of stretching and more on 'The Claman Countdown.'
Novo CEO outlines long-term strategy amid Trump-era drug talks: ‘We’re here to stay’
Novo Nordisk President and CEO Mike Doustdar joins ‘Mornings with Maria’ to discuss the launch of the first GLP-1 weight-loss pill in the U.S., the lawsuit against Hims & Hers and talks with the Trump administration on drug pricing.
Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Telehealth company Hims & Hers cancels $49 monthly weight-loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.
Pfizer CEO addresses growing competition in weight-loss drugs
Pfizer CEO Albert Bourla discusses Pfizer’s Q4 adjusted earnings and the competitive landscape for weight-loss drugs on ‘The Claman Countdown.’
Restaurant owner reveals surprising impact of Ozempic on dining habits
Celebrity chef and restaurant owner Andrew Gruel joins ‘Varney & Co.’ to break down the surprising ways weight loss drugs are hitting restaurant menus, alcohol sales and profit margins across the country.
Novo Nordisk executive reports high interest for once-daily, oral weight-loss pill
Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss medication on FOX Business, saying there's "a lot of excitement."
Wegovy rolls out once-daily weight loss pill; Novo Nordisk exec says not ‘much difference’
Novo Nordisk executive vice president of U.S. operations Dave Moore discusses the drugmaker’s newly launched once-daily oral weight-loss pill on ‘The Claman Countdown.’
Lara Trump defends new nutrition standards for America’s kids
‘My View’ host Lara Trump joins ‘Varney & Co.’ to react to new federal dietary guidelines, warn about processed foods and childhood chronic disease and push back on Democratic attacks against ICE.
Trump to reward states that adopted MAHA policies from rural health care fund
'The Big Money Show' panel weighs in on President Donald Trump's move to reward states that have adopted MAHA policies and discuss the rural health care system.
Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend
Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand for high-protein foods and fitness gear.
San Francisco sues 10 major food manufacturers over ultra-processed foods
City attorney files groundbreaking lawsuit against 10 food manufacturers, claiming ultra-processed products fuel public health crisis with rising disease rates.
Bala co-founder reveals how a sabbatical sparked a fitness revolution
Bala Bangles CEO and co-founder Natalie Holloway joins ‘Mornings with Maria’ to discuss turning a $5,000 startup into a national sensation after landing a $900K deal on ‘Shark Tank.’
FDA Commissioner Dr. Marty Makary: We've never had this 'essential' conversation on health
FDA Commissioner Dr. Marty Makary addresses why obesity is on the decline and discusses the Trump administration's deal that slashes related drug costs on 'The Evening Edit.'
Pfizer wins 'fantastic deal' after $10B obesity drug fight with Novo Nordisk
Pfizer Chairman and CEO Albert Bourla joins 'Mornings with Maria' to discuss the company’s $10 billion acquisition of obesity drug startup Metsera, its competition with Novo Nordisk and his plans to expand their weight-loss drug pipeline.
Jillian Michaels calls IOC’s potential ban on transgender athletes a ‘win for women’
Fitness guru Jillian Michaels joins ‘Varney & Co.’ to analyze a report that the International Olympic Committee is considering banning transgender athletes from women’s events.
Weight-loss pills replacing GLP-1 shots will be ready by March, Dr. Oz tells FOX Business
Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted in a FOX Business appearance.
Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition
Pfizer has won a $10 billion deal to acquire obesity drug developer Metsera, securing foothold in lucrative weight-loss treatment market.
Trump says Ozempic prices will be 'much lower' for Americans
President Donald Trump said there will Ozempic prices will be lower after negotiations with Novo Nordisk as part of his broader initiative to reduce prescription drug costs.